Literature DB >> 7893968

Selective release of a processed form of interleukin 1 alpha.

N Watanabe1, Y Kobayashi.   

Abstract

Interleukin 1 alpha (IL-1 alpha) is synthesized as a 33 kDa form and proteolytically processed into a 17 kDa form. Although IL-1 alpha has no signal peptide, it is released from cells. To investigate the relationship between the processing and release of IL-1 alpha, human bladder carcinoma cells (HTB9 5637) which express IL-1 alpha constitutively, were treated with calcium ionophore (A23187). A23187 induced the processing of 33 kDa IL-1 alpha and selectively released processed 17 kDa IL-1 alpha, without any change in the release of 33 kDa IL-1 alpha. When extracellular calcium was chelated by EGTA, or when intracellular calpain was inhibited by the cell-permeable cysteine-protease inhibitor, E64d, the processing of 33 kDa IL-1 alpha was significantly blocked, the release of 33 kDa IL-1 alpha being unchanged. These results indicate that the release of IL-1 alpha was accompanied by the processing of 33 kDa IL-1 alpha.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7893968     DOI: 10.1016/1043-4666(94)90046-9

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  22 in total

1.  The precursor form of IL-1alpha is an intracrine proinflammatory activator of transcription.

Authors:  Ariel Werman; Rachel Werman-Venkert; Rosalyn White; Jae-Kwon Lee; Batsheva Werman; Yakov Krelin; Elena Voronov; Charles A Dinarello; Ron N Apte
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

2.  Sustained calpain inhibition improves locomotor function and tissue sparing following contusive spinal cord injury.

Authors:  Chen-Guang Yu; James W Geddes
Journal:  Neurochem Res       Date:  2007-05-03       Impact factor: 3.996

3.  Intraspinal MDL28170 microinjection improves functional and pathological outcome following spinal cord injury.

Authors:  Chen-Guang Yu; Aashish Joshi; James W Geddes
Journal:  J Neurotrauma       Date:  2008-07       Impact factor: 5.269

4.  Granzyme B-dependent proteolysis acts as a switch to enhance the proinflammatory activity of IL-1α.

Authors:  Inna S Afonina; Graham A Tynan; Susan E Logue; Sean P Cullen; Michael Bots; Alexander U Lüthi; Emer P Reeves; Noel G McElvaney; Jan P Medema; Ed C Lavelle; Seamus J Martin
Journal:  Mol Cell       Date:  2011-10-21       Impact factor: 17.970

5.  Is there leaderless protein secretion in plants?

Authors:  Fang-yi Cheng; John D Williamson
Journal:  Plant Signal Behav       Date:  2010-02-11

6.  Increased interleukin-1 (IL-1) and imbalance between IL-1 and IL-1 receptor antagonist during acute inflammation in experimental Shigellosis.

Authors:  J Arondel; M Singer; A Matsukawa; A Zychlinsky; P J Sansonetti
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

Review 7.  Revisiting caspase-11 function in host defense.

Authors:  Tessie M Ng; Denise M Monack
Journal:  Cell Host Microbe       Date:  2013-07-17       Impact factor: 21.023

8.  Interleukin-1 alpha promotes tumor growth and cachexia in MCF-7 xenograft model of breast cancer.

Authors:  Suresh Kumar; Hiromitsu Kishimoto; Hui Lin Chua; Sunil Badve; Kathy D Miller; Robert M Bigsby; Harikrishna Nakshatri
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

9.  Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis.

Authors:  Kazuhide Watanabe; Yasuhiro Hasegawa; Hiroshi Yamashita; Kazue Shimizu; Yuanying Ding; Mayumi Abe; Hideki Ohta; Keiichi Imagawa; Kanji Hojo; Hideo Maki; Hikaru Sonoda; Yasufumi Sato
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

Review 10.  Dual functionality of interleukin-1 family cytokines: implications for anti-interleukin-1 therapy.

Authors:  N M Luheshi; N J Rothwell; D Brough
Journal:  Br J Pharmacol       Date:  2009-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.